Jennifer Kugel
Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Polymerase II | 36 | 2026 | 339 | 7.610 |
Why?
| | Transcription, Genetic | 40 | 2026 | 1485 | 5.530 |
Why?
| | RNA, Untranslated | 15 | 2016 | 124 | 3.280 |
Why?
| | Promoter Regions, Genetic | 28 | 2025 | 1241 | 2.590 |
Why?
| | DNA | 21 | 2023 | 1438 | 2.270 |
Why?
| | Heat-Shock Response | 5 | 2026 | 77 | 1.830 |
Why?
| | Transcription Factors, TFII | 9 | 2025 | 44 | 1.670 |
Why?
| | Transcription Factor TFIIH | 6 | 2025 | 40 | 1.660 |
Why?
| | RNA, Messenger | 13 | 2024 | 2822 | 1.510 |
Why?
| | HMGB1 Protein | 3 | 2022 | 50 | 1.380 |
Why?
| | Nucleic Acid Conformation | 14 | 2020 | 725 | 1.240 |
Why?
| | Protein Binding | 17 | 2025 | 2238 | 1.210 |
Why?
| | DNA-Binding Proteins | 7 | 2023 | 1478 | 1.200 |
Why?
| | Cleavage And Polyadenylation Specificity Factor | 2 | 2026 | 11 | 1.120 |
Why?
| | Single Molecule Imaging | 4 | 2025 | 40 | 1.100 |
Why?
| | RNA | 10 | 2020 | 929 | 1.020 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2023 | 526 | 1.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 3 | 2023 | 87 | 1.010 |
Why?
| | TATA-Box Binding Protein | 5 | 2013 | 20 | 0.990 |
Why?
| | Gene Expression Regulation | 11 | 2020 | 2604 | 0.920 |
Why?
| | Fluorescence Resonance Energy Transfer | 5 | 2016 | 176 | 0.920 |
Why?
| | Transcription Factor TFIIB | 5 | 2020 | 13 | 0.850 |
Why?
| | Herpesvirus 1, Human | 2 | 2021 | 80 | 0.770 |
Why?
| | TATA Box | 5 | 2017 | 22 | 0.750 |
Why?
| | HMGB2 Protein | 1 | 2021 | 4 | 0.730 |
Why?
| | HMGB Proteins | 1 | 2021 | 17 | 0.720 |
Why?
| | Immediate-Early Proteins | 1 | 2021 | 49 | 0.700 |
Why?
| | Tumor Suppressor Proteins | 1 | 2023 | 325 | 0.680 |
Why?
| | Herpes Simplex | 1 | 2021 | 94 | 0.660 |
Why?
| | TATA-Binding Protein Associated Factors | 2 | 2010 | 18 | 0.620 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 117 | 0.620 |
Why?
| | Escherichia coli | 2 | 2023 | 835 | 0.610 |
Why?
| | Proto-Oncogene Proteins c-jun | 3 | 2014 | 56 | 0.610 |
Why?
| | Muscle Development | 1 | 2020 | 114 | 0.610 |
Why?
| | Transcription Initiation Site | 2 | 2017 | 42 | 0.590 |
Why?
| | Ethanol | 1 | 2023 | 629 | 0.580 |
Why?
| | Transcription Factors | 6 | 2024 | 1703 | 0.570 |
Why?
| | Biochemistry | 2 | 2012 | 36 | 0.570 |
Why?
| | Transcription Termination, Genetic | 1 | 2018 | 20 | 0.570 |
Why?
| | RNA Interference | 1 | 2020 | 468 | 0.560 |
Why?
| | Chromatin | 8 | 2023 | 533 | 0.500 |
Why?
| | Kinetics | 11 | 2020 | 1651 | 0.490 |
Why?
| | Aptamers, Nucleotide | 2 | 2014 | 85 | 0.460 |
Why?
| | Genome | 2 | 2010 | 302 | 0.460 |
Why?
| | Proto-Oncogene Proteins c-fos | 3 | 2014 | 191 | 0.450 |
Why?
| | Short Interspersed Nucleotide Elements | 4 | 2010 | 11 | 0.450 |
Why?
| | Base Sequence | 12 | 2017 | 2169 | 0.430 |
Why?
| | Catalytic Domain | 3 | 2013 | 223 | 0.430 |
Why?
| | MicroRNAs | 2 | 2020 | 691 | 0.420 |
Why?
| | DNA Cleavage | 1 | 2013 | 8 | 0.400 |
Why?
| | Alu Elements | 6 | 2014 | 28 | 0.390 |
Why?
| | Humans | 51 | 2025 | 140898 | 0.380 |
Why?
| | Interleukin-2 | 6 | 2014 | 451 | 0.370 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2013 | 103 | 0.370 |
Why?
| | Response Elements | 2 | 2023 | 89 | 0.360 |
Why?
| | Gene Silencing | 2 | 2010 | 197 | 0.360 |
Why?
| | Transcription Initiation, Genetic | 2 | 2025 | 19 | 0.360 |
Why?
| | Breast Neoplasms | 1 | 2023 | 2235 | 0.340 |
Why?
| | RNA, Long Noncoding | 1 | 2013 | 173 | 0.330 |
Why?
| | Transcription Factor TFIID | 2 | 2010 | 21 | 0.330 |
Why?
| | Recombinant Fusion Proteins | 2 | 2012 | 672 | 0.320 |
Why?
| | Animals | 26 | 2020 | 37579 | 0.320 |
Why?
| | Models, Genetic | 8 | 2018 | 587 | 0.320 |
Why?
| | Microscopy, Fluorescence | 2 | 2025 | 418 | 0.320 |
Why?
| | Nucleosomes | 3 | 2021 | 155 | 0.320 |
Why?
| | Eukaryota | 1 | 2010 | 61 | 0.310 |
Why?
| | RNA, Bacterial | 2 | 2009 | 189 | 0.310 |
Why?
| | NIH 3T3 Cells | 4 | 2018 | 149 | 0.300 |
Why?
| | RNA, Small Nuclear | 1 | 2009 | 37 | 0.300 |
Why?
| | Cyclin-Dependent Kinases | 2 | 2025 | 130 | 0.290 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2012 | 403 | 0.290 |
Why?
| | Phosphorylation | 4 | 2026 | 1758 | 0.270 |
Why?
| | Protein Structure, Tertiary | 1 | 2010 | 858 | 0.270 |
Why?
| | Models, Biological | 8 | 2013 | 1822 | 0.270 |
Why?
| | Binding Sites | 7 | 2020 | 1315 | 0.270 |
Why?
| | Chromatin Immunoprecipitation | 3 | 2018 | 136 | 0.250 |
Why?
| | Mice | 15 | 2020 | 18057 | 0.250 |
Why?
| | Saccharomyces cerevisiae | 2 | 2026 | 556 | 0.250 |
Why?
| | Protein Subunits | 2 | 2025 | 228 | 0.240 |
Why?
| | Cell Line | 4 | 2023 | 2879 | 0.240 |
Why?
| | Templates, Genetic | 6 | 2016 | 63 | 0.220 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2007 | 321 | 0.220 |
Why?
| | Trans-Activators | 1 | 2006 | 394 | 0.200 |
Why?
| | Ribonuclease III | 3 | 2012 | 44 | 0.200 |
Why?
| | DEAD-box RNA Helicases | 3 | 2012 | 86 | 0.190 |
Why?
| | Breast | 1 | 2023 | 155 | 0.190 |
Why?
| | Oligoribonucleotides | 1 | 2002 | 52 | 0.180 |
Why?
| | DNA-Directed RNA Polymerases | 3 | 2009 | 63 | 0.180 |
Why?
| | Cartilage | 1 | 2023 | 191 | 0.180 |
Why?
| | NFATC Transcription Factors | 2 | 2013 | 94 | 0.180 |
Why?
| | Transcription Factor TFIIA | 3 | 2010 | 7 | 0.160 |
Why?
| | Fluorescence | 1 | 2020 | 161 | 0.160 |
Why?
| | Osteochondrosis | 1 | 2019 | 2 | 0.160 |
Why?
| | Poultry Diseases | 1 | 2019 | 13 | 0.150 |
Why?
| | Myoblasts | 1 | 2020 | 82 | 0.150 |
Why?
| | Macular Degeneration | 2 | 2012 | 185 | 0.150 |
Why?
| | 3' Untranslated Regions | 1 | 2020 | 149 | 0.150 |
Why?
| | Transcription Factor AP-1 | 3 | 2014 | 88 | 0.150 |
Why?
| | RNA, Double-Stranded | 1 | 2019 | 59 | 0.150 |
Why?
| | Genome, Human | 1 | 2021 | 421 | 0.150 |
Why?
| | Cartilage, Articular | 1 | 2023 | 332 | 0.150 |
Why?
| | Bone Resorption | 1 | 2019 | 84 | 0.150 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2020 | 544 | 0.150 |
Why?
| | DNA Footprinting | 2 | 2010 | 33 | 0.150 |
Why?
| | HEK293 Cells | 1 | 2021 | 737 | 0.140 |
Why?
| | Osteoblasts | 1 | 2019 | 136 | 0.140 |
Why?
| | CRISPR-Cas Systems | 1 | 2020 | 153 | 0.140 |
Why?
| | Optical Imaging | 1 | 2019 | 64 | 0.140 |
Why?
| | Homeostasis | 1 | 2021 | 636 | 0.130 |
Why?
| | Retinal Pigment Epithelium | 3 | 2012 | 77 | 0.130 |
Why?
| | Osteomyelitis | 1 | 2019 | 143 | 0.130 |
Why?
| | Down-Regulation | 2 | 2010 | 638 | 0.130 |
Why?
| | Consensus Sequence | 1 | 2017 | 74 | 0.130 |
Why?
| | Protein Conformation | 2 | 2013 | 939 | 0.130 |
Why?
| | Histones | 1 | 2022 | 638 | 0.130 |
Why?
| | Transcription Factors, General | 1 | 2016 | 5 | 0.120 |
Why?
| | Hot Temperature | 3 | 2011 | 406 | 0.120 |
Why?
| | Protein Multimerization | 2 | 2014 | 194 | 0.120 |
Why?
| | Binding, Competitive | 2 | 2015 | 196 | 0.120 |
Why?
| | Cell Differentiation | 2 | 2023 | 1999 | 0.120 |
Why?
| | Adenosine Triphosphate | 1 | 1998 | 490 | 0.120 |
Why?
| | Inflammasomes | 2 | 2019 | 142 | 0.120 |
Why?
| | Molecular Sequence Data | 6 | 2013 | 2917 | 0.120 |
Why?
| | Fluorescent Dyes | 2 | 2016 | 324 | 0.110 |
Why?
| | Staphylococcal Infections | 1 | 2019 | 391 | 0.110 |
Why?
| | Protein Domains | 1 | 2016 | 303 | 0.110 |
Why?
| | SELEX Aptamer Technique | 1 | 2014 | 16 | 0.110 |
Why?
| | HeLa Cells | 3 | 2013 | 639 | 0.110 |
Why?
| | Mammals | 1 | 2016 | 286 | 0.110 |
Why?
| | Optical Tweezers | 1 | 2014 | 21 | 0.100 |
Why?
| | Genes, Reporter | 1 | 2014 | 272 | 0.100 |
Why?
| | In Vitro Techniques | 3 | 2005 | 1093 | 0.100 |
Why?
| | Epigenetic Repression | 1 | 2013 | 4 | 0.100 |
Why?
| | Buffers | 1 | 2013 | 56 | 0.100 |
Why?
| | Transcription Elongation, Genetic | 1 | 2013 | 23 | 0.100 |
Why?
| | Virus Replication | 1 | 2015 | 531 | 0.100 |
Why?
| | Host-Pathogen Interactions | 1 | 2015 | 370 | 0.090 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 150 | 0.090 |
Why?
| | RNA Stability | 1 | 2013 | 116 | 0.090 |
Why?
| | Oligonucleotides, Antisense | 3 | 2011 | 110 | 0.090 |
Why?
| | Chromosome Mapping | 1 | 2013 | 504 | 0.090 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 183 | 0.090 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2012 | 105 | 0.090 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2012 | 270 | 0.090 |
Why?
| | Cyclin H | 1 | 2011 | 2 | 0.090 |
Why?
| | Phenanthrenes | 1 | 2011 | 12 | 0.090 |
Why?
| | Diterpenes | 1 | 2011 | 27 | 0.090 |
Why?
| | Geographic Atrophy | 1 | 2012 | 91 | 0.080 |
Why?
| | Cell Cycle | 1 | 2014 | 598 | 0.080 |
Why?
| | Models, Chemical | 2 | 2003 | 272 | 0.080 |
Why?
| | Yeasts | 1 | 2010 | 52 | 0.080 |
Why?
| | Isomerism | 1 | 2010 | 55 | 0.080 |
Why?
| | Serine | 1 | 2011 | 148 | 0.080 |
Why?
| | Deoxyribonuclease I | 1 | 2010 | 40 | 0.080 |
Why?
| | DNA Helicases | 1 | 2011 | 141 | 0.080 |
Why?
| | RNA Polymerase III | 1 | 2009 | 28 | 0.080 |
Why?
| | Genomic Imprinting | 1 | 2009 | 26 | 0.070 |
Why?
| | Protein Kinases | 1 | 2011 | 308 | 0.070 |
Why?
| | Actins | 1 | 2011 | 423 | 0.070 |
Why?
| | Recombinant Proteins | 4 | 2010 | 1361 | 0.070 |
Why?
| | Drosophila melanogaster | 1 | 2010 | 237 | 0.070 |
Why?
| | Blotting, Western | 1 | 2011 | 1231 | 0.070 |
Why?
| | Gene Regulatory Networks | 1 | 2010 | 310 | 0.070 |
Why?
| | Biological Products | 1 | 2011 | 239 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2011 | 2056 | 0.060 |
Why?
| | Cattle | 2 | 2000 | 991 | 0.060 |
Why?
| | Sigma Factor | 1 | 2007 | 42 | 0.060 |
Why?
| | Sequence Deletion | 1 | 2007 | 183 | 0.060 |
Why?
| | Peptide Elongation Factor 1 | 1 | 2006 | 9 | 0.060 |
Why?
| | Heat Shock Transcription Factors | 1 | 2006 | 18 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2014 | 2497 | 0.060 |
Why?
| | Dimerization | 1 | 2006 | 195 | 0.060 |
Why?
| | Adenoviridae | 3 | 2005 | 200 | 0.060 |
Why?
| | Algorithms | 1 | 2013 | 1763 | 0.060 |
Why?
| | Precipitin Tests | 1 | 2004 | 98 | 0.050 |
Why?
| | Cell Nucleus | 2 | 2004 | 607 | 0.050 |
Why?
| | Receptors, Retinoic Acid | 1 | 2022 | 41 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 985 | 0.050 |
Why?
| | Jurkat Cells | 2 | 2013 | 138 | 0.040 |
Why?
| | RNA, Transfer | 1 | 2002 | 139 | 0.040 |
Why?
| | Chondrocytes | 1 | 2023 | 228 | 0.040 |
Why?
| | Models, Molecular | 2 | 2020 | 1602 | 0.040 |
Why?
| | Doxorubicin | 1 | 2022 | 358 | 0.040 |
Why?
| | Transcriptional Activation | 2 | 2013 | 377 | 0.040 |
Why?
| | Phenotype | 2 | 2023 | 3172 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2011 | 2156 | 0.040 |
Why?
| | Staphylococcus | 1 | 2019 | 75 | 0.040 |
Why?
| | Chickens | 1 | 2019 | 189 | 0.040 |
Why?
| | DNA, Superhelical | 1 | 1998 | 11 | 0.040 |
Why?
| | Tissue Engineering | 1 | 2023 | 429 | 0.040 |
Why?
| | Necrosis | 1 | 2019 | 247 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2023 | 655 | 0.030 |
Why?
| | Cell Survival | 2 | 2011 | 1129 | 0.030 |
Why?
| | Enzyme Assays | 1 | 2016 | 25 | 0.030 |
Why?
| | Enzymes, Immobilized | 1 | 2016 | 29 | 0.030 |
Why?
| | Protein Stability | 1 | 2016 | 175 | 0.030 |
Why?
| | Female | 1 | 2023 | 75540 | 0.030 |
Why?
| | Thermodynamics | 2 | 2007 | 424 | 0.030 |
Why?
| | Mutation | 3 | 2013 | 3999 | 0.030 |
Why?
| | Luciferases | 1 | 2013 | 148 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 817 | 0.020 |
Why?
| | Flavonoids | 1 | 2012 | 82 | 0.020 |
Why?
| | Time Factors | 3 | 2009 | 6944 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2012 | 189 | 0.020 |
Why?
| | Epoxy Compounds | 1 | 2011 | 31 | 0.020 |
Why?
| | Drugs, Chinese Herbal | 1 | 2011 | 22 | 0.020 |
Why?
| | Transfection | 1 | 2013 | 936 | 0.020 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2012 | 164 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2012 | 801 | 0.020 |
Why?
| | Adenosine Triphosphatases | 1 | 2011 | 159 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2011 | 331 | 0.020 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2010 | 150 | 0.020 |
Why?
| | Esterification | 1 | 2009 | 9 | 0.020 |
Why?
| | DNA Primers | 1 | 2010 | 508 | 0.020 |
Why?
| | Cell Death | 1 | 2011 | 387 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4407 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2012 | 842 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2012 | 746 | 0.020 |
Why?
| | Sequence Analysis | 1 | 2007 | 36 | 0.020 |
Why?
| | Enhancer Elements, Genetic | 1 | 2007 | 188 | 0.010 |
Why?
| | Plasmids | 1 | 2004 | 365 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2011 | 4199 | 0.010 |
Why?
| | Genes, Viral | 1 | 2001 | 92 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2010 | 2003 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 2001 | 224 | 0.010 |
Why?
| | Nucleotides | 1 | 2001 | 127 | 0.010 |
Why?
| | Signal Transduction | 1 | 2012 | 5148 | 0.010 |
Why?
|
|
Kugel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|